New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 24, 2014
10:26 EDTCRUS, SKX, ATHN, IRBT, SWKS, CMG, INO, CROX, PBYIOptions with decreasing implied volatility
Options with decreasing implied volatility: INO PBYI UVXY CROX IRBT CMG SWKS SKX ATHN CRUS
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
November 20, 2015
16:20 EDTCMGOn The Fly: Top stock stories for Friday
Stocks on Wall Street began the session sharply higher, saw their highs in morning trading, and then slowly bled lower throughout much of the session. The averages still held on to gains, giving them their fourth winning session out of five this week and putting the finishing touch on one of the strongest weekly advances for stocks this year. ECONOMIC EVENTS: In the U.S., no major economic data was released. In Asia, China's Securities Regulatory Commission has restarted initial public offerings for five companies to list on the Shanghai stock exchange and five in Shenzhen, ending a five-month freeze on IPOs. COMPANY NEWS: Shares of Nike (NKE) advanced $6.84, or 5.44%, to $132.62 after the footwear and sports apparel giant announced a two-for-one stock split, a $12B stock repurchase program and plans to boost its dividend... Shares of Chipotle Mexican Grill (CMG) dropped sharply after the Center for Disease Control announced that three additional states have reported people infected within the E. coli outbreak linked to the company's restaurants. 45 people infected with the outbreak strain have now been reported from a total of six states - two in California, two in Minnesota, one in New York, one in Ohio, 13 in Oregon, and 26 in Washington - the CDC said. Chipotle shares closed down $76.52, or 12.5%, to $534.99 after the update. MAJOR MOVERS: Among the notable gainers was Cabela's (CAB), which gained $4.34, or 10.4%, to $46.10 after Bloomberg reported, citing people familiar with the matter, that the sporting goods retailer is receiving takeover interest and considering whether to commence a sales process. Also higher was Sarepta (SRPT), which jumped $7.29, or about 28%, to $33.36 after the FDA posted briefing materials ahead of next week's advisory committee meeting to review the New Drug Application for Kyndrisa, a Duchenne muscular dystrophy treatment under development from competitor BioMarin (BMRN). The committee review scheduled for Sarepta's rival drug, eteplirsen, is scheduled for January. BioMarin shares fell $6.11, or 5.9%, to $97.00 after the documents, which Piper Jaffray analyst Joshua Schimmer said take a "very harsh view" of the drug, were made public. Also lower were shares of Nimble Storage (NMBL), which plunged $10.34, or 50.7%, to $10.05 and was downgraded by at least eleven research firms following the company's significantly weaker than expected Q3 results and outlook. Peer Pure Storage (PSTG), which is scheduled to conduct its first earnings call as a public company in early December, also slid 15.3% to $14.74. INDEXES: The Dow rose 91.06, or 0.5%, to 17,823.81, the Nasdaq gained 31.28, or 0.62%, to 5,104.92, and the S&P 500 advanced 7.93, or 0.38%, to 2,089.17.
15:52 EDTCMGChipotle price target lowered to $750 from $830 at SunTrust
Subscribe for More Information
15:33 EDTCMGChipotle provides update on E. coli investigation
Subscribe for More Information
14:58 EDTSWKSDA Davidson technology analyst holds an analyst/industry conference call
Subscribe for More Information
14:54 EDTCMGChipotle shares plunge, levels to watch
Subscribe for More Information
14:37 EDTCMGChipotle says working closely with officials on E. coli issue, Bloomberg reports
Subscribe for More Information
14:34 EDTCMGChipotle options active after CDC says three states added to E. coli outbreak
Subscribe for More Information
14:27 EDTCMGChipotle drops after CDC says three states added to E.coli outbreak
Three additional states have reported people infected with the outbreak strain of Shiga toxin-producing Escherichia coli O26 infections linked to Chipotle Mexican Grill restaurants, the Center for Disease Control announced. 45 people infected with the outbreak strain of STEC O26 have now been reported from a total of 6 states: two in California, two in Minnesota, one in New York, one in Ohio, thirteen in Oregon, and twenty-six in Washington, the CDC said. Shares of Chipotle are down over 6% to $572.19 in afternoon trading following the CDC's update.
14:23 EDTCMGChipotle falls over 5% following CDC report on E. Coli outbreak
Subscribe for More Information
November 19, 2015
15:12 EDTPBYIPuma Biotechnology plans to file consent revocation statement with SEC
Subscribe for More Information
12:23 EDTSKXSkechers announces 'favorable' ruling in Nike lawsuit
Skechers (SKX) announced that it has won a ruling over Nike's (NKE) wholly-owned subsidiary Converse relating to the Converse Chuck Taylor shoe. In a November 17 opinion, the Chief Administrative Law Judge of the ITC, the Honorable Charles Bullock, ruled that Skechers' Twinkle Toes and BOBS product lines do not infringe Converse's registered trademark for the Chuck Taylor midsole. In making his ruling, the Judge noted that both of the Skechers product lines feature prominent branding and that the Twinkle Toes line contains design features that "create enough differences that the shoes bearing them cannot be said to be similar to [the Chuck Taylor]." The Judge also stated that the survey evidence concluded that there was no likelihood that consumers would confuse the Skechers designs with those of Converse's Chuck Taylor designs. In addition, the Judge ruled that Converse has no common law trademark rights in the Chuck Taylor midsole because the design is not distinctive, not famous and has failed to acquire secondary meaning, Skechers said.
07:05 EDTSWKSMicrosemi announces revised proposal to acquire PMC-Sierra deemed 'superior'
Subscribe for More Information
November 18, 2015
08:28 EDTPBYILeerink to hold a bus tour
Subscribe for More Information
November 17, 2015
15:02 EDTATHNathenahealth announced new services agreement with TeamPraxis
athenahealth and TeamPraxis, a physician service organization in Hawaii, announced a new services agreement which enables TeamPraxis to access and use the athenaNet platform to implement and support the athenaOne suite of services and athenaCommunicator Enterprise population health service.
11:23 EDTATHNBarclays says sell athenahealth as new customers get harder to find
Barclays downgraded athenahealth (ATHN) to Underweight, the firm's equivalent of a Sell rating, in a note to investors today. The company's prospects in the ambulatory care market look weak and its growth rate appears to be unsustainable, the firm contended. athenahealth provides cloud-based services and mobile applications to medical groups WHAT'S NEW: After analyzing the ambulatory enterprise market, Barclays analyst Eric Percher reported that only 12 of the 100 largest names on the list are potential targets for athenahealth. Additionally, those dozen groups are much smaller than the ones with which athenahealth made deals in 2014 and earlier this year, wrote Percher. Given his findings, the analyst expects athenahealth's revenue growth to decline going forward. In order to accelerate its growth, athenahealth needs large contract wins and those are unlikely to occur in the near-term, predicted the analyst, who downgraded the stock to Underweight from Equal Weight and lowered his price target on the name to $110 from $140. WHAT'S NOTABLE: JPMorgan analyst Michael Newshel assumed lead coverage of athenahealth today with an Overweight rating and $170 price target. In his note this morning on the space, Newshel said his firm's latest hospital CIO survey indicates there will be no slowdown in HIT investments despite the electronic health records adoption cycle maturing. PRICE ACTION: In morning trading, athenahealth fell 6.6% to $152.22.
10:02 EDTPBYIHigh option volume stocks
Subscribe for More Information
10:00 EDTATHNOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Airgas (ARG) downgraded on valuation at KeyBanc... BHP Billiton (BHP) downgraded to Neutral from Buy at Clarksons Platou... Chesapeake (CHK) downgraded to Neutral from Buy at Sterne Agee CRT... ChipMOS (IMOS) downgraded to Equal Weight from Overweight at Morgan Stanley... Clovis (CLVS) downgraded to Neutral from Conviction Buy at Goldman... Cooper Companies (COO) downgraded to Market Perform from Outperform at Wells Fargo... Five Below (FIVE) downgraded to Neutral from Buy at Sterne Agee CRT... Grainger (GWW) downgraded to Underweight from Neutral at Atlantic Equities... Hess Corp. (HES) downgraded to Perform from Outperform at Oppenheimer... J Sainsbury (JSAIY) downgraded to Neutral from Buy at Citi... Kindred Biosciences (KIN) downgraded to Market Perform from Outperform at BMO Capital... Leju (LEJU) downgraded to Neutral from Buy at BofA/Merrill... Lombard Medical (EVAR) downgraded to Equal Weight from Overweight at Barclays... Osiris (OSIR) downgraded to Sell from Hold at Brean Capital... Polaris Industries (PII) downgraded on anemic ORV growth at Wedbush... SQM (SQM) downgraded to Hold from Buy at HSBC... Southwestern Energy (SWN) downgraded to Underperform from Neutral at Sterne Agee CRT... Starwood (HOT) downgraded to Outperform from Buy at CLSA... Urban Outfitters (URBN) downgraded to Hold from Buy at Cantor... WM Morrison (MRWSY) downgraded to Sell from Neutral at Citi... adidas (ADDDY) downgraded to Sector Perform from Outperform at RBC Capital... athenahealth (ATHN) downgraded to Underweight from Equal Weight at Barclays.
07:52 EDTSKXMorgan Stanley to hold a conference
Subscribe for More Information
06:26 EDTATHNThe Advisory Board initiated with an Overweight at JPMorgan
Subscribe for More Information
05:43 EDTATHNathenahealth downgraded to Underweight from Equal Weight at Barclays
Barclays analyst Eric Percher downgraded athenahealth to Underweight saying the company's physician and revenue growth will decline moving forward. An analysis of the ambulatory enterprise market indicates that potential athenahealth targets among the 100 largest health systems number only 12, Percher tells investors in a research note. Big enterprise wins are needed to drive growth but are "few and far between," the analyst contends. He cut his price target for athenahealth to $110 from $140. The provider of cloud-based services for medical groups and health systems closed yesterday up $1.77 to $162.98.
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use